Whole genome and exome sequencing associated six novel loci with serum B12 (CD320, TCN2, ABCD4, MMAA, MMACHC) or folate levels (FOLR3) with cardiovascular diseases, cancers, and neurodegenerative disorders. Here, CD320 is linked to cardiovascular disorder.